Cardiac Effect of FABP4 Inhibitor: A Novel Therapeutic Target for Diabetes Mellitus and Atherosclerosis

被引：0
|
作者：
Lamounier-Zepter, Valeria
Look, Christiane
Bornstein, Stefan R.
Morano, Ingo
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A483 / A483
页数：1
相关论文
共 50 条
  • [41] Elevated levels of circulating FABP4 predict preeclampsia in women with type 1 diabetes
    Kelly, C. B.
    Hookham, M. B.
    Yu, J. Y.
    Jenkins, A. J.
    Hanssen, K. F.
    Henriksen, T.
    Garg, S. K.
    Aston, C. E.
    Lyons, T. J.
    DIABETOLOGIA, 2016, 59 : S124 - S125
  • [42] Glucagon and alpha-cells as a novel therapeutic target in the management of diabetes mellitus
    Petunina, N. A.
    Truhina, L. V.
    Sinicyna, E. I.
    Shestakova, M. V.
    DIABETES MELLITUS, 2013, 16 (03): : 35 - 40
  • [43] Combined Virtual Screening and Substructure Search for Discovery of Novel FABP4 Inhibitors
    Cai, Haiyan
    Wang, Ting
    Yang, Zhuo
    Xu, Zhijian
    Wang, Guimin
    Wang, He-Yao
    Zhu, Weiliang
    Chen, Kaixian
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2017, 57 (09) : 2329 - 2335
  • [44] Noncoding RNAs as therapeutic targets in atherosclerosis with diabetes mellitus
    Tang, Ningning
    Jiang, Shaoyan
    Yang, Yanyan
    Liu, Shaoyan
    Ponnusamy, Murugavel
    Xin, Hui
    Yu, Tao
    CARDIOVASCULAR THERAPEUTICS, 2018, 36 (04)
  • [45] Association Between Serum Fabp4 Levels, Pericardial Adipose Tissue Volume, and Plaque Characteristics in Patients With Type 2 Diabetes Mellitus
    Nakahara, Takehiro
    Kawai-Kowase, Keiko
    Nakahara, Rieko
    Utsugi, Toshihiro
    Iso, Tatsuya
    Arai, Masashi
    Tomono, Shoichi
    Tsushima, Yoshito
    Murakami, Masami
    Kurabayashi, Masahiko
    CIRCULATION, 2013, 128 (22)
  • [46] Oridonin attenuates atherosclerosis by inhibiting foam macrophage formation and inflammation through FABP4/PPARγ signalling
    Zhang, Ming
    Hou, Lianjie
    Tang, Wanying
    Lei, Weixing
    Lin, Huiling
    Wang, Yu
    Long, Haijiao
    Lin, Shuyun
    Chen, Zhi
    Wang, Guangliang
    Zhao, Guojun
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2023, 27 (24) : 4155 - 4170
  • [47] Vaccination Against FABP4 for Preventing High-Fat-Induced Insulin Resistance and Atherosclerosis in Mice
    Jin, Xinye
    Zou, Dajin
    DIABETES, 2012, 61 : A85 - A85
  • [48] Endothelial dysfunction as a novel therapeutic target in atherosclerosis
    Shimokawa, H
    DRUG NEWS & PERSPECTIVES, 1999, 12 (05) : 271 - 277
  • [49] Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis
    Li, Bin
    Li, Weihong
    Li, Xiaoli
    Zhou, Hong
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (08) : 1216 - 1227
  • [50] Novel directions in inflammation as a therapeutic target in atherosclerosis
    Verweij, Simone L.
    van der Valk, Fleur M.
    Stroes, Erik S. G.
    CURRENT OPINION IN LIPIDOLOGY, 2015, 26 (06) : 580 - 585
12345